SB1412 103RD GENERAL ASSEMBLY

LRB103 26068 KTG 52423 b

103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB1412

Introduced 2/6/2023, by Sen. Laura M. Murphy

SYNOPSIS AS INTRODUCED:

20 ILCS 2205/2205-40 new
20 ILCS 2205/2205-45 new

Amends the Department of Healthcare and Family Services Law of the Civil Administrative Code of Illinois. Provides that the Department of Healthcare and Family Services shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Requires the Department to adopt rules to implement and administer the program. Establishes the State Generic Drug Label Task Force to study the cost savings of establishing a State prescription generic drug label. Contains provisions concerning membership on the Task Force; Task Force meetings; administrative support to the Task Force; reporting requirements; and other matters. Provides that the provisions creating the Task Force are repealed on January 1, 2025. Effective immediately.

A BILL FOR

AN ACT concerning State government.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Department of Healthcare and Family Services Law of the Civil Administrative Code of Illinois is amended by adding Sections 2205-40 and 2205-45 as follows:

(20 ILCS 2205/2205-40 new)

Sec. 2205-40. Generic prescription drug contracting. The Department of Healthcare and Family Services shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. The Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. The Department shall adopt rules necessary to implement and administer the program created under this Section.

(20 ILCS 2205/2205-45 new)

Sec. 2205-45. State Generic Drug Label Task Force.

(a) There is hereby established the State Generic Drug Label Task Force to study the cost savings of establishing a State prescription generic drug label.

(b) The Task Force shall consist of the following members:

(1) one member of the House of Representatives appointed by the Speaker of the House of Representatives in consultation with the Minority Leader of the House of Representatives;

(2) one member of the Senate appointed by the President of the Senate in consultation with the Minority Leader of the Senate;

(3) one member who is a representative of the Department of Healthcare and Family Services appointed by the Director of Healthcare and Family Services;

(4) one member from a managed care organization appointed by the Director of Healthcare and Family Services; and

(5) one member who is a pharmacist appointed by the Director of Healthcare and Family Services.

(c) Members of the Task Force shall serve without compensation.

(d) The Department shall provide administrative support to the Task Force.

(e) The Task Force shall select from among its members a chairperson. The Task Force shall convene and hold its first meeting beginning in September 2023, and shall hold at least one meeting per month until the issuance of the report of the Task Force under subsection (f).

(f) The Task Force shall study the cost savings of establishing a State prescription generic drug label, and all relevant and related matters, and issue a report on its findings to the Governor and the General Assembly on or before December 31, 2023.

(g) This Section is repealed on January 1, 2025.

Section 99. Effective date. This Act takes effect upon becoming law.